Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001140361-25-009919
Filing Date
2025-03-21
Accepted
2025-03-21 18:39:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2677
  Complete submission text file 0001140361-25-009919.txt   4179
Mailing Address WALLSTRASSE 16 BERLIN 2M 10179
Business Address WALLSTRASSE 16 BERLIN 2M 10179 49 89 2153 9035
ATAI Life Sciences N.V. (Subject) CIK: 0001840904 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40493 | Film No.: 25761882
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ATAI LIFE SCIENCES N.V. WALLSTRASSE 16 BERLIN 2M 10179
Business Address
Johnson Anne Nagengast (Reporting) CIK: 0001976640 (see all company filings)

Type: 144